Alex Lombardy: Reveals the Copper Peptide Breakthrough that the $52.37 Billion Dollar Hair Loss Industry Tried To Erase Alex Lombardy MD, IAT Hair Restoration Expert, Featured in the International Journal of Trichology October 5 2025 1 The Hair Regrowth Peptide So Strong It Repairs Burnt Skin Copper peptides specifically GHK-Cu are one of the biggest breakthroughs in hair loss science
community oncology practices found GLP-1 use was associated with significantly better overall survival across six tumor types - breast, prostate, colorectal, lung, liver and kidney - with a roughly one-third reduction in the risk of death
AO epigallocatechin-3-gallate, a most abundant catechin in green tea, reduces gingival inflammation, prevent bone resorption and limit the growth of periodontal pathogens, thus promoting periodontal health.[138] Organosulfur-compound diallyl sulfide enhances AO activities by scavenging superoxide ions and enhancing GSHPX levels, thus unveiling a significant antimicrobial effect against the Aggregatibacter actinomycetemcomitans .[139] Recent reports suggest that the topical use of esterified glutathione could potentially minimize effects of OS with raised intracellular levels of glutathione and acceleration of wound healing by improving the capacity of fibroblasts and keratinocytes.[88] Oxidative stress is one of the underlying factors explaining the systemic pathophysiological mechanisms associated with the chronic inflammatory conditions as periodontitis.[99] A decrease in salivary reduced-glutathione levels in type 1 diabetes mellitus patients may have a role in the destruction of the periodontium by predisposing the periodontal tissues to OS.[70] It can be postulated that patients with reduced or depleted glutathione content, as in systemic disorders with compromised AO defenses,[82] may be more prone to further increase in OS, and worsening of the condition when superimposed with periodontal infection
It makes sense to try reducing the dose and monitor weight closely
Category S0 (non-approved substances) covers pharmacological compounds without approval by any regulatory agency for use in humans
